Research Article
Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
| Patient # | Age at initial treatment (yrs) | Time between 1st and 2nd Brachytherapy (mo) | Pre-salvage PSA (ng/mL) | Presalvage PSA (ng/dL) | Follow-up (mo) | Time to nadir (mo) |
| 1 | 57 | 38 | 6.3 | 3.6 | 149 | 21 | 2 | 61 | 32 | 5.3 | 3.6 | 132 | 31 | 3 | 65 | 26 | 4.5 | 4.4 | 86 | 73 | 4 | 63 | 34 | 10 | 2.5 | 111 | 6 | 5 | 59 | 26 | 4.9 | 2.7 | 119 | 10 | 6 | 50 | 67 | 8 | 14.9 | 83 | 10 | 7 | 48 | 287 | x | 8.6 | 34 | 22 | 8 | 60 | 123 | 7.2 | 17.41 | 10 | 9 | 9 | 55 | 120 | 6.3 | 1.53 | 67 | 7 | 10 | 57 | 19 | 5.3 | 3.49 | 49 | 48 | 11 | 48 | 25 | 6.93 | 2.77 | 41 | 41 | 12 | 66 | 4 | 4.7 | 1.86 | 15 | 4 | 13 | 44 | 31 | 8.7 | 2.41 | 41 | 29 | 14 | 50 | 87 | 7.4 | 7.3 | 39 | 33 | 15 | 66 | 42 | 19.1 | 1.68 | 52 | 9 | 16 | 71 | 45 | 6.4 | 3.11 | 40 | 5 | 17 | 63 | 48 | 8.2 | 13.8 | 49 | 3 | 18 | 42 | 50 | 1 | 0.98 | 40 | 41 | 19 | 58 | 105 | x | 11.58 | 52 | 17 | 20 | 59 | 48 | 5.7 | 4.24 | 25 | 7 | 21 | 72 | 21 | 5.8 | 3.1 | 21 | 15 |
| Mean | 57.8 | 62.9 | 6.9 | 5.5 | 61.4 | 20.9 | Median | 59.0 | 45.0 | 6.3 | 3.5 | 49.0 | 15.0 | SD | 8.4 | 60.2 | 3.5 | 4.9 | 37.9 | 18.3 | | 21 | 21 | 19 | 21 | 21 | 21 |
|
|
x = data point not known.
|